CVS - CVS: Shares Decimated But I'm Buying For The 4.6% Yield And Rebound Potential

2024-05-31 01:21:07 ET

Summary

• CVS stock has plunged after reporting Q1 2024 results, presenting a potential buying opportunity due to its undervaluation.
• This stock now offers a 4.63% yield and CVS has built a unique ecosystem that makes it an attractive investment.
• Medicare Advantage presents a headwind for insurance companies in 2024, but this is a buying opportunity because it offers long-term growth potential.

CVS Health Corporation ( CVS ) is well-known for its CVS pharmacy retail stores. It also has CVS Caremark, which is a pharmacy benefits manager, Oak Street Health, which is a primary care company, and Aetna, which is one of the largest health insurance providers. This stock plunged after the company reported Q1 2024 results and it made me want to take a fresh look at this stock because the valuation has changed so much in such a short time....

For further details see: